Study | Timepoint | Medication adherence and outcome | Physical activity adherence and outcome | Quality of life and outcome |
---|---|---|---|---|
Gross et al. (2019) [23] | Immediately post-intervention at week 48 | 100%: Using self-reported adherence n (%): [Int. 174(73) vs. Cont. 173(69)]; p = 0·89 |  |  |
Ruan et al. (2017) [20] | Immediately post-intervention at month 6 | 100%: Using CPCRA adherence n (%): [Int. 42(89.3) vs. Cont. 34(72.3)]; Z = 2.208; p = 0.027 80%-99% Using CPCRA adherence n (%): [Int. 3(6.4) vs. Cont. 3(6.4)]; Z = 2.208; p = 0.027  < 79% Using CPCRA adherence n (%): [Int. 2(4.3) vs. Cont. 10(21.3)]; Z = 2.208; p = 0.027 Using Visual Analogue Scale (VAS) mean ± SD: [Int. (98.72 ± 2.35) vs. Cont. (93.11 ± 6.51)]; Z = 2.735; p = 0.006 |  |  |
Nsagha et al. (2016) [26] | Immediately post-intervention at week 4 | Using the interviewer-administered self-report questionnaire %: [Int. 64.4% vs. Cont. 44.2%] Z = NR; p = 0.05 |  |  |
Sabin et al. (2015) [27] | Immediately post-intervention at month 9 following 3 months of pre-intervention | Using wise-pill device mean ± SD: [Int. (96.2 ± 6.4) vs. Cont. (89.1 ± 15.9)]; Z = NR; p = 0.003 |  |  |
Moore et al. (2015) [24] | Immediately post-intervention at day 30 | Using MEMS mean ± SD:: [Int. (86.2 ± 12.7) vs. Cont. (84.8 ± 18.1)]; cliff’s d = 0.01; p = 0.95 Using self-reported VAS mean ± SD: [Int. (95.8 ± 6.6) vs. Cont. (92.4 ± 13.0)]; Z = NR; p = 0.44 |  |  |
Maduka and Tobin-West., (2013) [22] | Immediately post-intervention at month 4 | Using self-reported adherence questionnaire n (%): [Int. 40(76.9) vs. Cont. 29(55.8)]; Z = 0.224; p = 0.022 |  |  |
Mbuagbaw et al. (2012) [21] | Immediately post-intervention at month 6 | Using Visual Analogue Scale (VAS) n (%): [Int. 72(71.3) vs. Cont. 66(66.7)]; Z = NR; p = 0.542 Using self-report n (%): [Int. 80(79.2) vs. Cont. 78(79.0)]; Z = NR; p =  > 0.999 Using pharmacy refill data mean ± SD: [Int. (3.8 ± 1.48) vs. Cont. (3.7 ± 1.34)]; Z = NR; p = 0.617 |  | Using SF-12 scale score Quality of life assessment form: [Int. (3.79 ± 0.585) vs. Cont. (3.75 ± 0.583)]; Z = NR; p = 0.629 |
da Costa et al. (2012) [18] | Immediately post-intervention at month 4 | Using self-reported adherence n (%): [Int. 8(100.00) vs. Cont. 12(92.31)]; Z = 0.8038; p = 0.4215 Using pill counting n (%): [Int. 5(62.50) vs. Cont. 6(46.15)]; Z = 0.7284; p = 0.4664 Using micro-electronic monitoring systems (MEMS) n (%): [Int. 6(75.00) vs. Cont. 7(53.85)]; Z = 0.9694; p = 0.3324 |  |  |
Pop-eleches et al. (2011) [25] | Immediately post-intervention at week 48 | Using the medication event monitoring system (MEMS) n/N: 4 intervention groups (daily short messages, weekly short messages, daily long messages and weekly long messages) with the control group Summary group (All daily reminder groups, irrespective of message length): [Int. 0.41 vs. Cont. 0.40]; Z = NR; p = 0.92 Summary group (All weekly reminder groups, irrespective of message length): [Int. 0.53 vs. Cont. 0.40]; Z = NR; p = 0.03 Summary group (All short reminder groups, irrespective of message frequency): [Int. 0.47 vs. Cont. 0.40]; Z = NR; p = 0.27 Summary group (All long reminder groups, irrespective of message frequency): [Int. 0.47 vs. Cont. 0.40]; Z = NR; p = 0.24 Subgroups Subgroup 1 (daily short messages): [Int. 0.40 vs. Cont. 0.40]; Z = NR; p = 0.97 Subgroup2 (weekly short messages): [Int. 0.53 vs. Cont. 0.40]; Z = NR; p = 0.07 Subgroup3 (daily long messages): [Int. 0.42 vs. Cont. 0.40]; Z = NR; p = 0.85 Subroup4 (weekly long messages): [Int. 0.53 vs. Cont. 0.40]; Z = NR; p = 0.08 |  |  |
Lester et al. (2010) [19] | Immediately post-intervention | Using self-reported questionnaire n (%): [Int. 168(62) vs. Cont. 132(50)]; Z = NR; p = 0.006 |  |  |